Biomira Stock Up 82 Pct on Cancer Vaccine
613909
Shares of Biomira Inc. (BRA.TO: Quote, Profile, Research) surged 82 percent on Friday on promising test results for a new lung cancer vaccine developed by Germany&#39;s Merck (MRCG.
753248
Shares of CoTherix Inc. shot up 30 percent to a new 52-week high Thursday following the Food and Drug Administration&#39;s approval of its lead product candidate, an inhaled treatment for high blood pressure in the arteries of the lungs.
474718
Nabi Biopharmaceuticals NABI.O on  Tuesday said its NicVAX nicotine vaccine showed promising  results in helping smokers quit smoking in a small clinical  trial, sending its shares up 23 percent in premarket activity.
683806
The biotech company reported net income of $833 million, or 71 cents per share, for the latest quarter.
13132
The Gaithersburg-based biotech firm MedImmune Inc. will resume production of its nasal-spray influenza vaccine and deliver an additional million doses by early January, the company and federal officials announced yesterday.
716051
The toy company's stock was up 82% today after a great Christmas.
584086
Biotech and pharmaceutical stocks showed no signs of slowing down Friday afternoon amid news that vaccine maker Chiron Corp. was going deliver its flu vaccine a month late this year because some lots had been contaminated.
199040
The Department of Health and Human Services announced Tuesday that flu vaccine maker Aventis Pasteur will be able to deliver 2.8 million more vaccine
236457
Roche Holding AG on Monday said new data  showed cancer drug MabThera significantly extended survival and  cured more patients with aggressive lymphoma than chemotherapy  alone.
354741
Nabi Biopharmaceuticals NABI.O on  Tuesday said its NicVAX nicotine vaccine showed promise in  helping smokers quit smoking in a small clinical trial, sending  its shares up 17 percent.
181264
The biopharmaceutical company raised $108 million in an initial public offering that priced below a reduced forecast range.
232138
MGI Pharma Inc. MOGN.O will spend up  to $85 million for a stake in SuperGen Inc. SUPG.O and global  rights to develop and sell SuperGen's experimental drug for an  often-fatal cancer of the bone marrow, the companies said on  Wednesday.
581751
THE REGION Idera Pharmaceuticals Inc. of Cambridge signed a drug-development deal with Merck &amp; Co. in which the New Jersey drug giant will pay $20 million cash and buy $10 million in stock for the rights to use Idera's immune-boosting technology in potential Merck vaccines. If the vaccines succeed, the deal could be worth up to $425 million in additional ...
291784
Preliminary OK of generic antidepressant perks up the stock's potential.
57826
The state Department of Health Services plans to start shipping an additional 271,000 doses of vaccine as early as Monday. Of those, 3,830 have been allocated to Stanislaus County.
567554
World&#39;s No.2 biotech company beats Wall Street consensus and raises its full-year profit forecast. NEW YORK  - Genentech Inc.
139125
Genentech Inc. DNA.N on Wednesday  posted a 50 percent rise in quarterly profit and raised its  full-year earnings forecast on strong sales of its new colon  cancer drug, sending its shares higher in after-hours trading.